These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3597752)

  • 1. Hemolytic activity and invasiveness in strains of Proteus penneri.
    Rozalski A; Kotełko K
    J Clin Microbiol; 1987 Jun; 25(6):1094-6. PubMed ID: 3597752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characterization of hemolytic activity of Proteus penneri].
    Rózalski A; Bartodziejska B; Wykrota M; Serwecińska L; Lukomski S; Kotełko K
    Med Dosw Mikrobiol; 1993; 45(1):79-83. PubMed ID: 8231450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-free and cell-bound hemolytic activities of Proteus penneri determined by different Hly determinants.
    Lukomski S; Serwecińska L; Rózalski A; Dziadek J; Staczek P; Jaworski A
    Can J Microbiol; 1991 Jun; 37(6):419-24. PubMed ID: 1913345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some biological features of Proteus bacilli. 2. Haemolytic activities of Proteus mirabilis and Proteus vulgaris strains.
    Kotelko K; Kaca W; Rózalski A; Deka M
    Acta Microbiol Pol; 1983; 32(4):345-51. PubMed ID: 6202102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and properties of haemolysins from clinical isolates of the Proteeae.
    Senior BW; Hughes C
    J Med Microbiol; 1988 Jan; 25(1):17-25. PubMed ID: 3275780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Investigation of hydrophobicity of Proteus vulgaris strains and ability of Proteus vulgaris and Proteus penneri strains to penetrate bladder membrane HCV T-29 cells ].
    Bartodziejska B; Błaszczyk A; Wykrota M; Kwil I; Babicka D; Rózalski A
    Med Dosw Mikrobiol; 2002; 54(4):335-45. PubMed ID: 12650056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The simultaneous production of both Hly- and Hpm-like hemolysins is characteristic of the Proteus penneri species.
    Serwecinska L; Pytlos M; Lukomski S; Jaworski A; Rózalski A
    J Basic Microbiol; 1997; 37(5):361-70. PubMed ID: 9373950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The production of HlyA toxin by Proteus penneri strains.
    Senior BW
    J Med Microbiol; 1993 Oct; 39(4):282-9. PubMed ID: 8411089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cell-bound and cell-free hemolytic activity of Proteus strains.
    Kaca W; Rózalski A
    Eur J Epidemiol; 1991 Mar; 7(2):159-65. PubMed ID: 2044713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The secreted hemolysins of Proteus mirabilis, Proteus vulgaris, and Morganella morganii are genetically related to each other and to the alpha-hemolysin of Escherichia coli.
    Koronakis V; Cross M; Senior B; Koronakis E; Hughes C
    J Bacteriol; 1987 Apr; 169(4):1509-15. PubMed ID: 3549692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic activity of the Proteus hemolysin HpmA.
    Swihart KG; Welch RA
    Infect Immun; 1990 Jun; 58(6):1861-9. PubMed ID: 2341182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proteus bacilli: features and virulence factors].
    Rózalski A; Kwil I; Torzewska A; Baranowska M; Staczek P
    Postepy Hig Med Dosw (Online); 2007; 61():204-19. PubMed ID: 17507868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural antibiotic susceptibility of Proteus spp., with special reference to P. mirabilis and P. penneri strains.
    Stock I
    J Chemother; 2003 Feb; 15(1):12-26. PubMed ID: 12678409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the haemolytic activity of Proteus mirabilis strains.
    Peerbooms PG; Verweij AM; MacLaren DM
    Antonie Van Leeuwenhoek; 1983 Apr; 49(1):1-11. PubMed ID: 6351736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteus virulence: involvement of the pore forming alpha-hemolysin (a short review).
    Tóth V; Emódy L
    Acta Microbiol Immunol Hung; 2000; 47(4):457-70. PubMed ID: 11056765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and serological characterization of the lipopolysaccharide from Proteus penneri 20 and classification of the cross-reacting Proteus penneri strains 10, 16, 18, 20, 32 and 45 in Proteus serogroup O17.
    Sidorczyk Z; Toukach FV; Zych K; Arbatsky NP; Drzewiecka D; Ziółkowski A; Shashkov AS; Knirel YA
    Arch Immunol Ther Exp (Warsz); 2002; 50(5):345-50. PubMed ID: 12455869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swarming growth and resistance of Proteus penneri and Proteus vulgaris strains to normal human serum.
    Kwil I; Kaźmierczak D; Różalski A
    Adv Clin Exp Med; 2013; 22(2):165-75. PubMed ID: 23709372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the O-polysaccharide of Proteus mirabilis O19 and reclassification of certain Proteus strains that were formerly classified in serogroup O19.
    Perepelov AV; Rózalski A; Bartodziejska B; Senchenkova SN; Knirel YA
    Arch Immunol Ther Exp (Warsz); 2004; 52(3):188-96. PubMed ID: 15247885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and serological classification of a collection of Proteus penneri clinical strains.
    Drzewiecka D; Zych K; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2004; 52(2):121-8. PubMed ID: 15179326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical properties of Proteus penneri lipopolysaccharides--one of the major Proteus sp. virulence factors.
    Palusiak A
    Carbohydr Res; 2013 Oct; 380():16-22. PubMed ID: 23896159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.